It is indicated to control high blood sugar levels in patients with type 2 diabetes.

Mild to moderate side effect has been observed such as skin rashes redness, or itching, Blurred vision, fast heart rate, Diarrhea constipation

This drug is to be cautiously used in patients with liver disease, heart disease, and thyroid problems, avoid sun exposure

It is contraindicated in people with Type1 diabetes or diabetic ketoacidosis liver or kidney disease; thyroid disease, glucose-6-phosphate dehydrogenase deficiency G6PD, hormonal conditions such as adrenal and pituitary insufficiency, pregnancy and breastfeeding

They are available in the following forms and strengths: glipizide immediate-release IR tablets, which come in 5 milligrams mg and 10 mg to be given orally before a meal & glipizide extended-release ER tablets, which come in 2.5 mg, 5 mg, and 10 mg to be given orally with food

We have also established roots and begun this new venture in other countries as well such as South Korea, France, Oman, Brazil, and Finland

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai